CA Stock MarketDetailed Quotes

ImmunoPrecise Antibodies Ltd (IPA)

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayMarket Closed Mar 6 09:30 ET
0Market Cap0.00P/E (TTM)

ImmunoPrecise Antibodies Ltd (IPA) Revenue Breakdown Overview

By Business/Source

Currency:CAD
2022/FY
Stock NameRevenueRatio
Project revenue17.36M89.63%
Product sales revenue1.65M8.53%
Cryostorage revenue356K1.84%

By Product

No Data

By Industry

No Data

By Country/Region

Currency:CAD
2022/FY
Stock NameRevenueRatio
Europe9.43M48.69%
United States of America6.82M35.20%
Australia1.54M7.95%
Other1.01M5.20%
Canada572K2.95%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
Nancy Pelosi Portfolio
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the conflict between the US and Iran has continued, with the Strait of Hormuz at a standstill. A surge in oil prices, compounded b Show More